Showing 1 - 10 of 1,937
A health insurer's Medical Loss Ratio (MLR) is the share of premiums spent on medical claims. The Affordable Care Act introduced minimum MLR provisions for all health insurance sold in fully-insured commercial markets, thereby capping insurer profit margins, but not levels. While intended to...
Persistent link: https://www.econbiz.de/10012957378
.S. regional hospital markets to instrument for market concentration. We then estimate the model using risk-adjusted Medicare data …
Persistent link: https://www.econbiz.de/10012979347
We use data from the Medicare Current Beneficiary Survey (MCBS) to document the medical spending of Americans aged 65 …
Persistent link: https://www.econbiz.de/10013021020
by Medicare expenditures, the answer is yes. During 1987-2001, low income households experienced an increase of 78 … receiving it, regardless of health status or preferences. Using Medicare claims data matched to zip code income, we find greater …
Persistent link: https://www.econbiz.de/10013247023
Increased health care spending has been argued to be largely due to technological change. Cost-effectiveness analysis is the main tool used by private and public third-party payers to prioritize adoption of the new technologies responsible for this growth. However, such analysis by payers...
Persistent link: https://www.econbiz.de/10013152593
In recent years, considerable attention has been devoted to the development of statistical methods for the analysis of uncertainty in cost-effectiveness analysis, with a focus on situations in which the analyst has patient-level data on the costs and health effects of alternative interventions....
Persistent link: https://www.econbiz.de/10013216128
Most medical cost-effectiveness analyses include future costs only for related illnesses but this approach is controversial. This paper demonstrates that cost-effectiveness analysis is consistent with lifetime utility maximization only if it includes all future medical and non-medical...
Persistent link: https://www.econbiz.de/10013235873
Despite the presence of Medicare, out-of-pocket medical spending is a large expenditure risk facing the elderly. While …
Persistent link: https://www.econbiz.de/10013120195
We estimate a model of drug demand and supply that incorporates insurance, advertising, and competition between branded and generic drugs within and across therapeutic classes. We use data on antiulcer drugs from 1991 to 2010. Our simulations show generics and ``me-too'' drugs each increased...
Persistent link: https://www.econbiz.de/10013074647
We demonstrate Medicare's influence on private insurers' payments for physicians' services. Using a large … administrative change in payments for surgical versus medical care, we find that private prices follow Medicare's lead. A $1 change … in Medicare's fees moved private prices by $1.16. A second set of Medicare payment changes, which generated area …
Persistent link: https://www.econbiz.de/10013074910